Boston Cambridge Biotech Networks Featured News

Boston Cambridge Biotech Networks News

• 

  Jounce pivots, agrees to $96.5M acquisition by mysterious biotech

  March 27, 2023 Comments Off on Jounce pivots, agrees to $96.5M acquisition by mysterious biotech

• 

  Struggling MD Anderson spinout files for bankruptcy protection

  March 27, 2023 Comments Off on Struggling MD Anderson spinout files for bankruptcy protection

• 

  Who’s spending and who’s cutting from Big Pharma’s $127B R&D budget? Here are the top 15 players

  March 27, 2023 Comments Off on Who’s spending and who’s cutting from Big Pharma’s $127B R&D budget? Here are the top 15 players

• 

  City of Boston: MassBio Convenes for Summit

  March 27, 2023 Comments Off on City of Boston: MassBio Convenes for Summit

• 

  Tausight Expands ePHI Security Intelligence Platform with new offering built on Google Cloud

  March 27, 2023 Comments Off on Tausight Expands ePHI Security Intelligence Platform with new offering built on Google Cloud

• 

  Arcaea, the biology-first beauty company, launches first ingredient technology, ScentARC™, focused on the deodorant category

  March 27, 2023 Comments Off on Arcaea, the biology-first beauty company, launches first ingredient technology, ScentARC™, focused on the deodorant category

• 

  Fallon Health & Autism Care Partners Announce Collaboration Focused on Care for Children & Families Impacted by Autism

  March 27, 2023 Comments Off on Fallon Health & Autism Care Partners Announce Collaboration Focused on Care for Children & Families Impacted by Autism

• 

  Codiak files for Chapter 11 bankruptcy as most executives head for the exit

  March 27, 2023 Comments Off on Codiak files for Chapter 11 bankruptcy as most executives head for the exit

• 

  Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes

  March 27, 2023 Comments Off on Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes

• 

  Labviva nets $20M Series A to ease life science procurement process

  March 27, 2023 Comments Off on Labviva nets $20M Series A to ease life science procurement process